These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 33525792)
21. Bioengineered human heparin with anticoagulant activity. Lord MS; Cheng B; Tang F; Lyons JG; Rnjak-Kovacina J; Whitelock JM Metab Eng; 2016 Nov; 38():105-114. PubMed ID: 27445159 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer. Suhovskih AV; Tsidulko AY; Kutsenko OS; Kovner AV; Aidagulova SV; Ernberg I; Grigorieva EV Front Oncol; 2014; 4():79. PubMed ID: 24782989 [TBL] [Abstract][Full Text] [Related]
23. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application. Hu P; Fang L; Chess EK Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018 [TBL] [Abstract][Full Text] [Related]
24. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. Iozzo RV J Cell Biol; 1984 Aug; 99(2):403-17. PubMed ID: 6235235 [TBL] [Abstract][Full Text] [Related]
25. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans. Brecher AS; Adamu MT Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460 [TBL] [Abstract][Full Text] [Related]
27. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship. Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660 [TBL] [Abstract][Full Text] [Related]
28. Sulfated glycosaminoglycans in protein aggregation diseases. Nishitsuji K; Uchimura K Glycoconj J; 2017 Aug; 34(4):453-466. PubMed ID: 28401373 [TBL] [Abstract][Full Text] [Related]
29. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis. Erickson DR; Ordille S; Martin A; Bhavanandan VP J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216 [TBL] [Abstract][Full Text] [Related]
30. Novel glycosaminoglycan precursors as anti-amyloid agents part II. Kisilevsky R; Szarek WA J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792 [TBL] [Abstract][Full Text] [Related]
31. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis. Chappell EP; Liu J Bioorg Med Chem; 2013 Aug; 21(16):4786-92. PubMed ID: 23313092 [TBL] [Abstract][Full Text] [Related]
32. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor. Foxall C; Holme KR; Liang W; Wei Z Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987 [TBL] [Abstract][Full Text] [Related]
33. Aggregation and cytotoxic properties towards cultured cerebrovascular cells of Dutch-mutated Abeta40 (DAbeta(1-40)) are modulated by sulfate moieties of heparin. Timmer NM; Schirris TJ; Bruinsma IB; Otte-Höller I; van Kuppevelt TH; de Waal RM; Verbeek MM Neurosci Res; 2010 Apr; 66(4):380-9. PubMed ID: 20036698 [TBL] [Abstract][Full Text] [Related]
34. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans. Warda M; Mao W; Toida T; Linhardt RJ Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047 [TBL] [Abstract][Full Text] [Related]
35. [Biosynthetic mechanism of the bioactive sulfated glycosaminoglycans]. Kitagawa H Yakugaku Zasshi; 2002 Jul; 122(7):435-50. PubMed ID: 12136640 [TBL] [Abstract][Full Text] [Related]
37. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups. Lortat-Jacob H; Grimaud JA Biochim Biophys Acta; 1992 Sep; 1117(2):126-30. PubMed ID: 1525174 [TBL] [Abstract][Full Text] [Related]